PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Phocean Nephrology Institute, Clinique Bouchard, Marseille, France.\', \'Association pour le Traitement des Urémiques en Provence, Marseille, France.\', \'Department of Cardiology, Clinique Bouchard, Marseille, France.\', \'Department of Endocrinology, Clinique Bouchard, Marseille, France.\', \'Laboratoire Cerballiance Provence, Marseille, France.\', \'Aix-Marseille Université, APHM, Unité des Virus Emergents (UVE) IRD 190, INSERM 1207, Laboratoire de Pharmacocinétique et Toxicologie, Hôpital La Timone, Marseille, France.\', \'Service de Pharmacologie Clinique et Pharmacovigilance, APHM, Institut de Neurosciences des Systèmes, Inserm UMR 1106, Université d\'Aix-Marseille, Marseille, France.\', \'Aix Marseille Université, INSERM, INRAE, C2VN, Marseille, France.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • 10.1093/ndt/gfaa191
?:hasPublicationType
?:journal
  • Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association
is ?:pmid of
?:pmid
?:pmid
  • 32844224
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • -1.0
?:rankingScore_hIndex
  • -1
is ?:relation_isRelatedTo_publication of
?:title
  • Hydroxychloroquine and azithromycin tolerance in haemodialysis patients during COVID-19 infection.
?:type
?:year
  • 2020

Metadata

Anon_0  
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://purl.org/net/provenance/ns#DataItem>
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2004/03/trix/rdfg-1/Graph>
<http://xmlns.com/foaf/0.1/primaryTopic> <https://research.tib.eu/covid-19/entity/32844224>
<http://xmlns.com/foaf/0.1/topic> Anon_0
<http://www.ontologydesignpatterns.org/cp/owl/informationrealization.owl#realizes> <https://research.tib.eu/covid-19/data/entity/32844224>
<http://purl.org/net/provenance/ns#createdBy>
Anon_1   (more)
expand all